-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Tong Ren Tang Sinopharm (03613.HK) announced that its subsidiary, Beijing Tong Ren Tang (Macau) Co., Ltd. (“Tong Ren Tang Macau Company”), received the “Certificate of Registration for Proprietary Chinese Medicines” issued by the Drug Administration of the Macau Special Administrative Region Government to allow the use of “Shi Lintong Granules [Tong Ren Tang]”, “Liver Health Pills [Tong Ren Tang]”, “Tongren Tang]”, “Tongren Tang”, “Champion Pills [Tong Ren Tang]” (hereinafter collectively referred to as “pharmaceuticals”) are special in Macau, People's Republic of China For sale in the administrative district (Macau).
Share
Listen to the news
Zhitong Finance App News, Tong Ren Tang Sinopharm (03613.HK) announced that its subsidiary, Beijing Tong Ren Tang (Macau) Co., Ltd. (“Tong Ren Tang Macau Company”), received the “Certificate of Registration for Proprietary Chinese Medicines” issued by the Drug Administration of the Macau Special Administrative Region Government, permitting the use of “Shi Lintong Granules [Tong Ren Tang]”, “Liver Health Pills [Tong Ren Tang]”, “Tongren Tang]”, “Tongren Tang”, “Champion Pills [Tong Ren Tang]” (hereinafter collectively referred to as “pharmaceuticals”) are special in Macau, People's Republic of China For sale in the administrative district (Macau).
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending